Compare Stocks

The Direxion Daily MSCI Emerging Markets Bull 3X Shares (EDC) is an exchange-traded fund that is based on the MSCI Emerging Markets index. The fund provides 3x leveraged exposure to a market-cap-weighted index of companies operating in emerging markets. EDC was launched on Dec 17, 2008 and is managed by Direxion.

Sasol Limited operates as an integrated chemical and energy company in South Africa. It offers alumina, such as battery materials, catalyst supports, abrasives and polishing, and polymer additives; cobalt fischer-tropsch; carbon-based products; recarburiser; graphite electrodes; mono-ethylene glycol, ethylene, propylene, sasfroth blends, sodium cyanide, caustic soda, hydrochloric acid, sulfuric acid, calcium chloride, chlorine, alcohols, aromatic blends, methyl alcohol, polyethylene, polypropylene, polyvinyl chloride, cresols, xylenols, phenols, limestone ammonium nitrate, ammonium nitrate solution, and nitric acid. The company also provides linear alkyl benzene, sulfonate, fatty alcohols, alkoxylates, ether sulfates, solvents, dispersants, diluents esters, macrogol/PEG, AHA esters, waxes, dispersants, diluents, ethanol, isopropyl, acetone, MIBK and ethyl acetate, C6-C20+ and guerbet alcohols, ethoxylates, propoxylates, carboxylates, sulfates, sulfonates, LAS salts, paraffins, and ethylene oxide. In addition, it offers alcohols, esters, ethers, carboxylic acids, surfactants, oil and water soluble polyglycols, formulation and surface modifiers, solvents and coalescents, wax cuts, blends and forms, FT hard waxes, waxes and blends, lubrication packages, plasticizers, nucleators, release agents, emulsifiers, dispersants, wetting agents, tank-mix adjuvant components, fertiliser additives, specialty solvents, specialty grade acetone, MEK, various ethanol blends, n and i-propanol and butanol, various C4+ alcohols, ethyl and butyl acrylate monomers, octene, hexene, and pentene. Further, it explores, develops, produces, markets, and distributes natural oil and gas, and associated products; markets fuels and lubricants; develops lower-carbon energy solutions; operates coal mines; trades and transports oil, petrochemicals, and chemical products and derivatives; and provides engineering services. Sasol Limited was founded in 1950 and is based in Johannesburg, South Africa.

Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. Its lead product is tremtelectogene empogeditemcel (trem-cel), an engineered hematopoietic stem cell (eHSC) product candidate that is in phase 1/2 trial to treat acute myeloid leukemia (AML) and other hematological malignancies. The company is also developing Mylotarg, a CD33-directed antibody drug conjugate (ADC) therapy for patients with leukemia; VCAR33, a CAR-T therapy designed to target CD33, a clinically validated target for AML, which are under preclinical and Phase 1/2 clinical studies; trem-cel + VCAR33 treatment system that is under preclinical studies for the treatment of AML; and CD33-CLL1 treatment system made with CD33-CLL1 multiplex-engineered eHSC and CD33-CLL1 multi-specific CAR-T, which are under preclinical studies for the treatment of AML. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.